Companies / Beta Bionics, Inc.
Beta Bionics, Inc.
Nasdaq: BBNXCIK 1674632IRVINE, CA
Financials · FY2025
Ownership
45.0M shares outstanding · as of Jul 27, 2026
Ownership
| Insiders | 2.75% | 1,238,630 |
| Institutions | 108.79% | 48,944,200 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 11
View all →| Insider | % of shares | Shares |
|---|---|---|
Saint SeanCEOPresident & CEO · Director | 0.97% | 437,809 |
Mensinger MikeChief Product Officer | 0.42% | 188,793 |
Russell Steven JonChief Medical Officer | 0.40% | 179,096 |
Feider StephenChief Financial Officer | 0.38% | 172,729 |
Hopman MarkChief Commercial Officer | 0.31% | 139,133 |
Michel Gerard JDirector | 0.07% | 33,509 |
Carney SeanDirector | 0.07% | 32,209 |
Dearen Danny L.Director | 0.03% | 15,244 |
Jones ChristyDirector | 0.03% | 15,244 |
Lezack AdamDirector | 0.03% | 12,432 |
Institutional holders 160
View all →| Holder | Value | % of shares |
|---|---|---|
| $152.23M | 11.10% | |
| $131.45M | 9.59% | |
| $108.78M | 7.94% | |
| $105.41M | 7.69% | |
| $77.23M | 5.63% | |
| $76.17M | 5.56% | |
| $67.59M | 4.93% | |
| $52.34M | 7.42% | |
| $40.44M | 2.95% | |
| $40.10M | 2.93% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q3 2025 as of | Farallon Capital Management LLC 13F manager | New | Common stock | $85.72M | +4.3M | 4,313,920 9.59% of shares | high |
| Q1 2026 as of | Norges Bank 13F manager | Exit | Common stock | $-10.34M | -339K -100.00% | 0 | medium |
| Q4 2025 as of | Norges Bank 13F manager | New | Common stock | $10.34M | +339K | 339,300 0.75% of shares | medium |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | Common stock | $7.15M | +235K +118.68% | 432,340 0.96% of shares | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $6.68M | +426K +14.63% | 3,340,171 7.42% of shares | medium |
| Q1 2026 as of | Bruce & Co., Inc. 13F manager | New | Common stock | $5.52M | +551K | 550,700 1.22% of shares | medium |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | Add | Common stock | $5.34M | +533K +627.19% | 617,915 1.37% of shares | medium |
| Q1 2026 as of | Deerfield Management Company, L.P. 13F manager | Add | Common stock | $3.86M | +386K +41.11% | 1,324,000 2.94% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Farallon Capital Partners, L.P. | Passive13G/A | — |
| RTW Investments, LP | Passive13G/A | — |
| Point72 Asset Management, L.P. | Passive13G | — |
| Wellington Management Group LLP | Passive13G/A | — |
| Wellington Hadley Harbor Aggregator IV, L.P. | Passive13G/A | — |
| Soleus BB SPV, LLC | Passive13G/A | — |
| Farallon Capital Partners, L.P. | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| BBNX | — | 08659B102 |